| Entry |
|
|---|
| Name |
Iratumumab (USAN)
|
|---|
| Activity |
Oncological diseases;
Treatment of relapsed or refractory CD30 positive lymphoma including Hodgkin's disease
|
|---|
| Comment |
Monoclonal antibody
|
|---|
| Target |
|
|---|
| Pathway |
hsa04060 Cytokine-cytokine receptor interaction | |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokine receptors
TNF receptor family
TNFRSF8 (CD30) [HSA:943] [KO:K05145]
Iratumumab
D04612 Iratumumab (USAN)
 |
|---|
| Other DBs |
|
|---|
